{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:45:54Z","timestamp":1768740354099,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.phrs.2004.07.004","type":"journal-article","created":{"date-parts":[[2004,9,8]],"date-time":"2004-09-08T10:33:15Z","timestamp":1094639595000},"page":"69-78","source":"Crossref","is-referenced-by-count":8,"title":["Selegiline modifies the extinction of responding following morphine self-administration, but does not alter cue-induced reinstatement, reacquisition of morphine reinforcement, or precipitated withdrawal"],"prefix":"10.1016","volume":"51","author":[{"given":"Kenneth","family":"Grasing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaunteng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2004.07.004_bib1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/sj.bjp.0703826","article-title":"Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B","volume":"132","author":"Youdim","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.phrs.2004.07.004_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0006-2952(78)90525-7","article-title":"Deprenil, loss of selectivity for inhibition of b-type MAO after repeated treatment","volume":"27","author":"Waldmeier","year":"1978","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.phrs.2004.07.004_bib3","first-page":"752","article-title":"l-Methamphetamine pharmacokinetics and pharmacodynamics for assessment of in vivo deprenyl-derived l-methamphetamine","volume":"288","author":"Melega","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2004.07.004_bib4","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1523\/JNEUROSCI.13-09-04042.1993","article-title":"Rescue of axotomized immature rat facial motoneurons by R(\u2212)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition","volume":"13","author":"Ansari","year":"1993","journal-title":"J Neurosci"},{"key":"10.1016\/j.phrs.2004.07.004_bib5","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1523\/JNEUROSCI.18-03-00932.1998","article-title":"Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (\u2212)-deprenyl","volume":"18","author":"Wadia","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.phrs.2004.07.004_bib6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/exnr.2000.7563","article-title":"Selegiline combined with enriched-environment housing attenuates spatial learning deficits following focal cerebral ischemia in rats","volume":"167","author":"Puurunen","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1016\/j.phrs.2004.07.004_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1517\/13543784.11.4.491","article-title":"The potential of dopamine agonists in drug addiction","volume":"11","author":"Kosten","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.phrs.2004.07.004_bib8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0006-3223(02)01454-3","article-title":"A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation","volume":"53","author":"George","year":"2003","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.phrs.2004.07.004_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00008877-200209000-00008","article-title":"Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies","volume":"13","author":"Volkow","year":"2002","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.phrs.2004.07.004_bib10","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.phrs.2004.07.004_bib11","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/j.1471-4159.1992.tb10033.x","article-title":"Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence","volume":"58","author":"Acquas","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.phrs.2004.07.004_bib12","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1460-9568.1999.00488.x","article-title":"Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal","volume":"11","author":"Diana","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.phrs.2004.07.004_bib13","first-page":"841","article-title":"Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites: effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons","volume":"259","author":"Engberg","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2004.07.004_bib14","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1523\/JNEUROSCI.17-07-02267.1997","article-title":"Monoamine oxidase inhibition causes a long-term prolongation of the dopamine-induced responses in rat midbrain dopaminergic cells","volume":"17","author":"Mercuri","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.phrs.2004.07.004_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1020988215732","article-title":"Presynaptic dopaminergic function in the nucleus accumbens following chronic opiate treatment and precipitated withdrawal","volume":"24","author":"Ghosh","year":"1999","journal-title":"Neurochem Res"},{"key":"10.1016\/j.phrs.2004.07.004_bib16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0028-3908(98)00093-8","article-title":"Selegiline prevents long-term changes in dopamine efflux and stress immobility during the second and third weeks of abstinence following opiate withdrawal","volume":"37","author":"Grasing","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2004.07.004_bib17","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nn0901-943","article-title":"The role of withdrawal in heroin addiction: enhances reward or promotes avoidance?","volume":"4","author":"Hutcheson","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.phrs.2004.07.004_bib18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0091-3057(92)90197-N","article-title":"Modifications of striatal D2 dopaminergic postsynaptic sensitivity during development of morphine tolerance-dependence in mice","volume":"43","author":"Navarro","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.phrs.2004.07.004_bib19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0893-133X(96)00184-4","article-title":"Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal","volume":"16","author":"Wang","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2004.07.004_bib20","first-page":"271","article-title":"Dopaminergic mechanisms in precipitated withdrawal in morphine-dependent rats","volume":"200","author":"Ary","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2004.07.004_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0893-133X(00)00113-5","article-title":"Expression of fos-related antigens in the nucleus accumbens during opiate withdrawal and their attenuation by a D2 dopamine receptor agonist","volume":"23","author":"Walters","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2004.07.004_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pbb.2003.11.014","article-title":"Long-term opiate effects on amphetamine-induced dopamine release in the nucleus accumbens core and conditioned place preference","volume":"77","author":"He","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.phrs.2004.07.004_bib23","unstructured":"He S, Grasing K. Chronic opiate treatment enhances both cocaine-reinforced and cocaine-seeking behaviors following opiate withdrawal. Drug Alcohol Depend, in press."},{"key":"10.1016\/j.phrs.2004.07.004_bib24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/clpt.1994.204","article-title":"Pharmacokinetic aspects of l-deprenyl (selegiline) and its metabolites","volume":"56","author":"Heinonen","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.phrs.2004.07.004_bib25","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0006-2952(79)90293-4","article-title":"Cumulative effects of irreversible MAO inhibitors in vivo","volume":"28","author":"Felner","year":"1979","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.phrs.2004.07.004_bib26","series-title":"Behavioral Neuroscience: A Practical Approach","first-page":"117","article-title":"Intravenous drug self-administration techniques in animals","author":"Caine","year":"1993"},{"key":"10.1016\/j.phrs.2004.07.004_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s002130050702","article-title":"Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review","volume":"139","author":"Stafford","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2004.07.004_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00213-003-1442-x","article-title":"A new progressive ratio schedule for support of morphine self-administration in opiate dependent rats","volume":"168","author":"Grasing","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2004.07.004_bib29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00008877-200312000-00006","article-title":"Differences in morphine and cocaine reinforcement under fixed and progressive ratio schedules: effects of extinction, reacquisition and schedule design","volume":"14","author":"Li","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.phrs.2004.07.004_bib30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/oby.2002.66","article-title":"Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence","volume":"10","author":"Colantuoni","year":"2002","journal-title":"Obes Res"},{"key":"10.1016\/j.phrs.2004.07.004_bib31","first-page":"685","article-title":"Pretreatment with midazolam suppresses morphine withdrawal response in mice and rats","volume":"23","author":"Cao","year":"2002","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.phrs.2004.07.004_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(76)90259-4","article-title":"Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists","volume":"36","author":"Bhargava","year":"1976","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2004.07.004_bib33","first-page":"536","article-title":"Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions","volume":"205","author":"Gellert","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2004.07.004_bib34","first-page":"1","article-title":"Multiple, small dose administration of (\u2212)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition","volume":"328","author":"Knoll","year":"1994","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.phrs.2004.07.004_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/syn.10183","article-title":"Selegiline potentiates cocaine-induced increases in rodent nucleus accumbens dopamine","volume":"48","author":"Schiffer","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.phrs.2004.07.004_bib36","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1046\/j.1471-4159.1996.67041532.x","article-title":"Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo","volume":"67","author":"Lamensdorf","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.phrs.2004.07.004_bib37","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0028-3908(94)90116-3","article-title":"Effect of l-deprenyl, its structural analogues and some monoamine oxidase inhibitors on dopamine uptake","volume":"33","author":"Fang","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2004.07.004_bib38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0301-0082(94)90081-7","article-title":"The functional role of monoamine oxidases A and B in the mammalian central nervous system","volume":"42","author":"Berry","year":"1994","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.phrs.2004.07.004_bib39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0892-0362(02)00221-0","article-title":"Neuroprotection by propargylamines in Parkinson's disease: suppression of apoptosis and induction of prosurvival genes","volume":"24","author":"Maruyama","year":"2002","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.phrs.2004.07.004_bib40","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/0024-3205(93)90633-E","article-title":"The optimal dosage of (\u2212)deprenyl for increasing superoxide dismutase activities in several brain regions decreases with age in male Fischer 344 rats","volume":"52","author":"Carrillo","year":"1993","journal-title":"Life Sci"},{"key":"10.1016\/j.phrs.2004.07.004_bib41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0091-3057(96)00075-5","article-title":"Acquisition of a morris water maze task is impaired during early but not late withdrawal from morphine","volume":"55","author":"Dougherty","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.phrs.2004.07.004_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0091-3057(97)00047-6","article-title":"A two-separate-motivational-systems hypothesis of opioid addiction","volume":"59","author":"Bechara","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.phrs.2004.07.004_bib43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0893-133X(01)00293-7","article-title":"Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization","volume":"26","author":"De Vries","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2004.07.004_bib44","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s002130050944","article-title":"Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration","volume":"143","author":"De Vries","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2004.07.004_bib45","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0165-6147(03)00068-3","article-title":"The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction?","volume":"24","author":"Bonci","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.phrs.2004.07.004_bib46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF00215477","article-title":"A behavioural and neurochemical analysis of chronic and selective monoamine oxidase inhibition","volume":"92","author":"O\u2019Regan","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2004.07.004_bib47","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/clpt.1994.208","article-title":"Intravenous self-administration studies with l-deprenyl (selegiline) in monkeys","volume":"56","author":"Winger","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.phrs.2004.07.004_bib48","first-page":"61","article-title":"Are metabolites of l-deprenyl (selegiline) useful or harmful? Indications from preclinical research","volume":"48","author":"Yasar","year":"1996","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.phrs.2004.07.004_bib49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0149-7634(96)00008-5","article-title":"(\u2212)Deprenyl reduces delayed neuronal death of hippocampal pyramidal cells","volume":"21","author":"Paterson","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.phrs.2004.07.004_bib50","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00001756-199209000-00014","article-title":"Differential effects of deprenyl and MPTP on catecholamines and activity in BALB\/c mice","volume":"3","author":"Chia","year":"1992","journal-title":"Neuroreport"},{"key":"10.1016\/j.phrs.2004.07.004_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00213-002-1152-9","article-title":"Effects of selegiline (l-deprenyl) during smoking and short-term abstinence","volume":"163","author":"Houtsmuller","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2004.07.004_bib52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0893-133X(97)00113-9","article-title":"Neurobiological similarities in depression and drug dependence: a self-medication hypothesis","volume":"18","author":"Markou","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2004.07.004_bib53","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(79)90366-2","article-title":"Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity","volume":"57","author":"Porsolt","year":"1979","journal-title":"Eur J Pharm"},{"key":"10.1016\/j.phrs.2004.07.004_bib54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s002130100693","article-title":"Preference for a cocaine-associated environment is attenuated by augmented accumbal serotonin in cocaine withdrawn rats","volume":"156","author":"Harris","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2004.07.004_bib55","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0091-3057(99)00016-7","article-title":"Oral versus transdermal selegiline: antidepressant-like activity in rats","volume":"63","author":"Gordon","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.phrs.2004.07.004_bib56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4088\/JCP.v64n0216","article-title":"A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder","volume":"64","author":"Amsterdam","year":"2003","journal-title":"J Clin Psychiatr"},{"key":"10.1016\/j.phrs.2004.07.004_bib57","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0091-3057(92)90404-4","article-title":"Changes in spontaneous behavior in the dog following oral administration of l-deprenyl","volume":"43","author":"Head","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.phrs.2004.07.004_bib58","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0031-9384(96)80035-7","article-title":"Differences in some behavioural effects of deprenyl and amphetamine enantiomers in rats","volume":"60","author":"Timar","year":"1996","journal-title":"Physiol Behav"},{"key":"10.1016\/j.phrs.2004.07.004_bib59","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0091-3057(92)90484-W","article-title":"Deprenyl alters behavior and caudate dopamine through an amphetamine-like action","volume":"43","author":"Okuda","year":"1992","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661804001793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661804001793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T22:24:26Z","timestamp":1549232666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661804001793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S1043661804001793"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2004.07.004","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}